Lesokhin, A., Niesvizky, R., Arnulf, B., Larson, S., Strouse, C., Larrea, C. F. D., Vesole, D., Nagai, Y., Sullivan, S. T., Leip, E., Viqueira, A., Bahlis, N. (2025). Prolonged elranatamab treatment interruption in patients with relapsed or refractory multiple myeloma (RRMM) is feasible: A retrospective analysis from MagnetisMM-3. Blood. https://doi.org/10.1182/blood-2025-2269